US Patent 11053226 KRAS G12C inhibitors and methods of using the same
Patent 11053226 was granted and assigned to Amgen on July, 2021 by the United States Patent and Trademark Office.
Something went wrong.
Try refreshing the page.
Find more entities like US Patent 11053226 KRAS G12C inhibitors and methods of using the same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
